Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for AD-Associated Network Hyperexcitability
NCT02002819Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Oct 2014
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in Alzheimer's disease (AD), sponsored by University of Minnesota. Started Oct 2014; status: completed.
02
Drugs
levetiracetam
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02002819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002819.